What is ExactMed?
ExactMed Solutions operates as a specialized developer of high-fidelity software designed to optimize medication management within long-term care, assisted living, and home care settings. As a subsidiary of W.P. Malone, Inc., the company draws upon over two decades of pharmacy services expertise to bridge the gap between clinical operations and digital compliance. Their flagship product, iMAR, utilizes advanced touch-screen interfaces and barcode-driven technology to minimize medication errors and ensure real-time updates to administration records. By streamlining the critical med-pass workflow, ExactMed enables healthcare providers to meet stringent regulatory requirements while simultaneously enhancing operational profitability and clinical outcomes.
How much funding has ExactMed raised?
ExactMed has raised a total of $93K across 1 funding round:
Debt
$93K
Debt (2021): $93K with participation from PPP
Key Investors in ExactMed
PPP
Public-Private Partnership
What's next for ExactMed?
With the recent influx of capital, ExactMed is poised to scale its iMAR platform to meet the growing demand for intelligent, point-of-care medication management systems. The company intends to focus on deepening its market penetration within the long-term care sector, where the need for automated compliance and error-reduction tools remains acute. Future strategic initiatives will likely involve the integration of predictive analytics and enhanced interoperability features, further cementing the company's role as an essential partner for healthcare facilities striving to exceed quality-of-care standards. As the industry shifts toward more integrated digital health ecosystems, ExactMed is strategically positioned to lead the transition toward safer, more efficient medication administration protocols.
See full ExactMed company page
